Cleared Traditional

K911564 - E-Z LIFT IMAGING TABLE WITH FOOT PUMP (FDA 510(k) Clearance)

Class I Radiology device.

K911564 · Med-Tron Products, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1991
Decision
97d
Days
Class 1
Risk

K911564 is an FDA 510(k) clearance for the E-Z LIFT IMAGING TABLE WITH FOOT PUMP. Classified as Bed, Scanning, Nuclear (product code IYZ), Class I - General Controls.

Submitted by Med-Tron Products, Inc. (Miller Place, US). The FDA issued a Cleared decision on July 15, 1991 after a review of 97 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1350 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Med-Tron Products, Inc. devices

Submission Details

510(k) Number K911564 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 09, 1991
Decision Date July 15, 1991
Days to Decision 97 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
10d faster than avg
Panel avg: 107d · This submission: 97d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code IYZ Bed, Scanning, Nuclear
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 892.1350
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.